Product Information
IRBESARTAN 300 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.1530 per EA under NDC 33342004907. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
300 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342004907
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IRBESARTANApproval Type
Generic (ANDA)
FDA Application
ANDA202254On Market Since
9/27/2012
Pharmacological Classes
Price Statistics
The NADAC for IRBESARTAN 300 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 56.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1530 per EA |
|---|---|
| All-time high | $0.3794 (Jun 10, 2020) |
| All-time low | $0.1461 (Feb 18, 2026) |
| 52-week high | $0.1799 |
| 52-week low | $0.1461 |
| Median price | $0.2720 |
| Average price | $0.2636 |
| Largest weekly change | +33.1% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IRBESARTAN 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IRBESARTAN 300 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.1530 per EA (NDC 33342004907), effective Jun 24, 2026.
How has the price of IRBESARTAN 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for IRBESARTAN 300 MG TABLET has declined 56.4%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for IRBESARTAN 300 MG TABLET?
Since Nov 28, 2013, the NADAC for IRBESARTAN 300 MG TABLET has ranged from a low of $0.1461 (Feb 18, 2026) to a high of $0.3794 (Jun 10, 2020), with a median of $0.2720 per EA.
Are there cheaper alternatives to IRBESARTAN 300 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as IRBESARTAN 300 MG TABLET, but none are currently priced below it.
Who manufactures IRBESARTAN 300 MG TABLET?
IRBESARTAN 300 MG TABLET (NDC 33342004907) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification